Literature DB >> 16177055

Cutting edge: direct suppression of B cells by CD4+ CD25+ regulatory T cells.

Hyung W Lim1, Peter Hillsamer, Allison H Banham, Chang H Kim.   

Abstract

Regulatory T cells (Tregs) can potentially migrate to the B cell areas of secondary lymphoid tissues and suppress T cell-dependent B cell Ig response. T cell-dependent Ig response requires B cell stimulation by Th cells. It has been unknown whether Tregs can directly suppress B cells or whether they must suppress Th cells to suppress B cell response. We report here that Foxp3+ Tregs are found in T-B area borders and within germinal centers of human lymphoid tissues and can directly suppress B cell Ig response. Although Tregs can effectively suppress T cells, they can also directly suppress B cell response without the need to first suppress Th cells. The direct suppression of B cell Ig production by Tregs is accompanied by inhibition of Ig class switch recombination.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16177055     DOI: 10.4049/jimmunol.175.7.4180

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  206 in total

1.  T regulatory cells participate in the control of germinal centre reactions.

Authors:  Carla-Maria Alexander; Lorraine T Tygrett; Alexander W Boyden; Kristy L Wolniak; Kevin L Legge; Thomas J Waldschmidt
Journal:  Immunology       Date:  2011-06-03       Impact factor: 7.397

2.  Identification of a unique double-negative regulatory T-cell population.

Authors:  Byung O Lee; Joyce E Jones; Cory J Peters; David Whitacre; Lars Frelin; Janice Hughes; Won-Keun Kim; David R Milich
Journal:  Immunology       Date:  2011-12       Impact factor: 7.397

Review 3.  Immune modulation of inflammatory conditions: regulatory T cells for treatment of GvHD.

Authors:  Doreen Haase; Mireille Starke; Kia Joo Puan; Tuck Siong Lai; Olaf Rotzschke
Journal:  Immunol Res       Date:  2012-09       Impact factor: 2.829

4.  Regulatory T cells use programmed death 1 ligands to directly suppress autoreactive B cells in vivo.

Authors:  Janine Gotot; Catherine Gottschalk; Sonny Leopold; Percy A Knolle; Hideo Yagita; Christian Kurts; Isis Ludwig-Portugall
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-11       Impact factor: 11.205

5.  Effective modulation of CD4(+)CD25 (+high) regulatory T and NK cells in malignant patients by combination of interferon-α and interleukin-2.

Authors:  Guangxian Liu; Wuwei Yang; Mei Guo; Xiaoqing Liu; Naixiang Huang; Dingfeng Li; Zefei Jiang; Wenfeng Yang; Weijing Zhang; Hang Su; Zhiqing Liu; Tieqiang Liu; Dongmei Wang; Shan Huang; Bo Yao; Qiuhong Man; Lijuan Qiu; Xuedong Sun; Yuying Sun; Bing Liu
Journal:  Cancer Immunol Immunother       Date:  2012-06-22       Impact factor: 6.968

6.  Suppression of murine colitis and its associated cancer by carcinoembryonic antigen-specific regulatory T cells.

Authors:  Dan Blat; Ehud Zigmond; Zoya Alteber; Tova Waks; Zelig Eshhar
Journal:  Mol Ther       Date:  2014-03-06       Impact factor: 11.454

7.  Circulating CD4+ CD25+ regulatory T cells correlate with chronic hepatitis B infection.

Authors:  Guoping Peng; Shuping Li; Wei Wu; Zhen Sun; Yiqiong Chen; Zhi Chen
Journal:  Immunology       Date:  2007-08-31       Impact factor: 7.397

Review 8.  T Follicular Regulatory Cells and Antibody Responses in Transplantation.

Authors:  Elizabeth F Wallin
Journal:  Transplantation       Date:  2018-10       Impact factor: 4.939

9.  Effect of chronic morphine administration on circulating T cell population dynamics in rhesus macaques.

Authors:  William D Cornwell; Mark G Lewis; Xiaoxuan Fan; Jay Rappaport; Thomas J Rogers
Journal:  J Neuroimmunol       Date:  2013-09-20       Impact factor: 3.478

Review 10.  Tregs and rethinking cancer immunotherapy.

Authors:  Tyler J Curiel
Journal:  J Clin Invest       Date:  2007-05       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.